DoD Amyotrophic Lateral Sclerosis Therapeutic Development Award
ArchivedDefense Health Agency Contracting Activity - DHACA
Description
The Therapeutic Development Award supports the preclinical assessment of therapeutics for ALS. The proposed studies are expected to be empirical in nature and product-driven but may have a hypothesis-driven approach, provided the focus is on therapeutics. It is anticipated that the agents and/or data generated from these awards will lead to the advancement of new therapies for ALS.
Who can apply
- Unrestricted
Contact
301-682-5507; help@eBRAP.org
help@eBRAP.org
- PostedApr 1, 2014
- ClosesAug 20, 2014
- Program funding$4,800,000
- Expected awards2
- CFDA12.420
Pro insight
Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.
Unlock with Pro